[[Cyamemazine]]

CATEGORIES: Phenothiazines, Nitriles

Cyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class which was introduced by Theraplix in France in 1972 and later in Portugal as well.[tpl]cite book | url = http://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA280&dq=cyamemazine%20tercian&as_brr=3&pg=PA280#v=onepage&q=&f=false | title = Index nominum, international drug ... - Google Books | format = | work = | accessdate = [/tpl][tpl]cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | page = 534 | isbn = 0-412-46630-9 | oclc = | doi = | url = http://books.google.com/books?id=DeX7jgInYFMC&lpg=RA1-PA534&as_brr=3&pg=RA1-PA534#v=onepage&q=&f=false[/tpl][tpl]cite book | url = http://books.google.com/books?id=X2EyLsG4bcUC&lpg=PA397&dq=cyamemazine%20introduced&as_brr=3&pg=PA397#v=onepage&q=&f=false | title = Pharmaceutical manufacturing ... - Google Books | format = | work = | accessdate = [/tpl][tpl]cite journal | author = Bret P, Bret MC, Queuille E | title = patterns of antipsychotics in 13 French psychiatric hospitals | language = French | journal = L'Encéphale | volume = 35 | issue = 2 | pages = 129–38 |date=April 2009 | pmid = 19393381 | doi = 10.1016/j.encep.2008.03.007 | url = http://www.masson.fr/masson/S0013-7006(08)00103-6[/tpl] It is used for the treatment of schizophrenia and, especially, for psychosis-associated anxiety, due to its unique anxiolytic efficacy.[tpl]cite web | url = http://stahlonline.cambridge.org/prescribers_drug.jsf?page=0521683505c20_p115-120.html.therapeutics&name=Cyamemazine | title = Stahl's Essential Psychopharmacology - Cambridge University Press | format = | work = | accessdate = [/tpl][tpl]cite journal | author = Bourin M, Nic Dhonnchadha BA, Claude Colombel M, Dib M, Hascoët M | title = Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice | journal = Behavioural Brain Research | volume = 124 | issue = 1 | pages = 87–95 |date=September 2001 | pmid = 11423169 | doi = 10.1016/S0166-4328(01)00238-8| url = http://linkinghub.elsevier.com/retrieve/pii/S0166432801002388[/tpl]
Cyamemazine differs from other phenothiazine neuroleptics in that aside from the usual profile of dopamine, α1-adrenergic, H1, and mACh receptor antagonism,[tpl]cite journal | author = Hameg A, Bayle F, Nuss P, Dupuis P, Garay RP, Dib M | title = Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes | journal = Biochemical Pharmacology | volume = 65 | issue = 3 | pages = 435–40 |date=February 2003 | pmid = 12527336 | doi = 10.1016/S0006-2952(02)01515-0| url = http://linkinghub.elsevier.com/retrieve/pii/S0006295202015150[/tpl] it additionally produces potent blockade of several serotonin receptors, including 5-HT2A, 5-HT2C, and 5-HT7.[tpl]cite journal | author = Alvarez-Guerra M, d'Alché-Birée F, Wolf WA, Vargas F, Dib M, Garay RP | title = 5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity | journal = Psychopharmacology | volume = 147 | issue = 4 | pages = 412–7 |date=January 2000 | pmid = 10672635 | doi = 10.1007/s002130050010| url = http://link.springer.de/link/service/journals/00213/bibs/0147004/01470412.htm[/tpl][tpl]cite journal | author = Alvarez-Guerra M, Hameg A, Bayle F, Dib M, Garay RP | title = 5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle | journal = European Journal of Pharmacology | volume = 454 | issue = 2-3 | pages = 235–9 |date=November 2002 | pmid = 12421652 | doi = 10.1016/S0014-2999(02)02489-5| url = http://linkinghub.elsevier.com/retrieve/pii/S0014299902024895[/tpl][tpl]cite journal | author = Benyamina A, Arbus C, Nuss P, Garay RP, Neliat G, Hameg A | title = Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes | journal = European Journal of Pharmacology | volume = 578 | issue = 2-3 | pages = 142–7 |date=January 2008 | pmid = 17936750 | doi = 10.1016/j.ejphar.2007.09.025 | url = http://linkinghub.elsevier.com/retrieve/pii/S0014-2999(07)01053-9[/tpl] These actions have been implicated in cyamemazine's anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A), and despite being classified as a typical, it actually behaves like an atypical antipsychotic.[tpl]cite journal | author = Peinado J, Hameg A, Garay RP, Bayle F, Nuss P, Dib M | title = Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | volume = 367 | issue = 2 | pages = 134–9 |date=February 2003 | pmid = 12595954 | doi = 10.1007/s00210-002-0665-4 [/tpl]

==See also==

==References==


